- Home
- YHGJ vs COSM Comparison
YHGJ vs COSM Comparison
Compare YHGJ & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YHGJ | COSM |
|---|---|---|
| Founded | 1975 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 18.9M |
| IPO Year | 2006 | 2009 |
Fundamental Metrics
Financial Performance| Metric | YHGJ | COSM |
|---|---|---|
| Price | $3.17 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.6K | ★ 638.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.58 |
| EPS | N/A | ★ N/A |
| Revenue | $17,953,000.00 | ★ $54,426,402.00 |
| Revenue This Year | N/A | $20.69 |
| Revenue Next Year | N/A | $53.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.84 | ★ 1.97 |
| 52 Week Low | $0.47 | $0.28 |
| 52 Week High | $10.29 | $1.32 |
Technical Indicators
Market Signals| Indicator | YHGJ | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 39.53 |
| Support Level | $0.67 | $0.35 |
| Resistance Level | $3.98 | $0.50 |
| Average True Range (ATR) | 0.24 | 0.03 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 72.02 | 21.09 |
Price Performance
Historical ComparisonAbout YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.